SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA1
|
ENSG00000105991.7 | homeobox A1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA1 | hg19_v2_chr7_-_27135591_27135658 | -0.81 | 1.5e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_40010989 | 5.97 |
ENST00000315792.3
|
C8orf4
|
chromosome 8 open reading frame 4 |
chr11_+_114166536 | 5.96 |
ENST00000299964.3
|
NNMT
|
nicotinamide N-methyltransferase |
chr15_-_74501360 | 5.47 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr19_+_16435625 | 5.06 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr1_-_153517473 | 4.82 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr2_+_8822113 | 4.70 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
chr22_+_41968007 | 4.45 |
ENST00000460790.1
|
CSDC2
|
cold shock domain containing C2, RNA binding |
chr15_-_74501310 | 4.36 |
ENST00000423167.2
ENST00000432245.2 |
STRA6
|
stimulated by retinoic acid 6 |
chr8_-_27468945 | 3.99 |
ENST00000405140.3
|
CLU
|
clusterin |
chr8_-_27468842 | 3.63 |
ENST00000523500.1
|
CLU
|
clusterin |
chr15_-_64673630 | 3.60 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
chr8_-_27469196 | 3.38 |
ENST00000546343.1
ENST00000560566.1 |
CLU
|
clusterin |
chr19_-_38746979 | 3.13 |
ENST00000591291.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr15_-_64673665 | 3.06 |
ENST00000300035.4
|
KIAA0101
|
KIAA0101 |
chr12_+_48577366 | 3.01 |
ENST00000316554.3
|
C12orf68
|
chromosome 12 open reading frame 68 |
chr8_-_27468717 | 2.90 |
ENST00000520796.1
ENST00000520491.1 |
CLU
|
clusterin |
chr12_+_54402790 | 2.83 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
chr11_-_104034827 | 2.81 |
ENST00000393158.2
|
PDGFD
|
platelet derived growth factor D |
chr4_-_90229142 | 2.75 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
chr8_-_27462822 | 2.74 |
ENST00000522098.1
|
CLU
|
clusterin |
chr5_-_139930713 | 2.67 |
ENST00000602657.1
|
SRA1
|
steroid receptor RNA activator 1 |
chr7_+_139528952 | 2.59 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr7_+_74379083 | 2.56 |
ENST00000361825.7
|
GATSL1
|
GATS protein-like 1 |
chr2_-_239148599 | 2.53 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
chr10_+_60272814 | 2.49 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr5_+_133861790 | 2.45 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
chr11_-_104035088 | 2.36 |
ENST00000302251.5
|
PDGFD
|
platelet derived growth factor D |
chr11_-_126870655 | 2.30 |
ENST00000525144.2
|
KIRREL3
|
kin of IRRE like 3 (Drosophila) |
chr17_+_43239231 | 2.17 |
ENST00000591576.1
ENST00000591070.1 ENST00000592695.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
chr1_+_45140360 | 2.08 |
ENST00000418644.1
ENST00000458657.2 ENST00000441519.1 ENST00000535358.1 ENST00000445071.1 |
C1orf228
|
chromosome 1 open reading frame 228 |
chrX_-_52258669 | 2.07 |
ENST00000441417.1
|
XAGE1A
|
X antigen family, member 1A |
chr3_-_150264272 | 2.06 |
ENST00000491660.1
ENST00000487153.1 ENST00000239944.2 |
SERP1
|
stress-associated endoplasmic reticulum protein 1 |
chr16_+_28303804 | 2.02 |
ENST00000341901.4
|
SBK1
|
SH3 domain binding kinase 1 |
chr10_+_89264625 | 1.95 |
ENST00000371996.4
ENST00000371994.4 |
MINPP1
|
multiple inositol-polyphosphate phosphatase 1 |
chrX_-_10645773 | 1.94 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr19_+_7743387 | 1.85 |
ENST00000597959.1
|
CTD-3214H19.16
|
CTD-3214H19.16 |
chr11_-_126870683 | 1.84 |
ENST00000525704.2
|
KIRREL3
|
kin of IRRE like 3 (Drosophila) |
chr3_+_14444063 | 1.80 |
ENST00000454876.2
ENST00000360861.3 ENST00000416216.2 |
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6 |
chr5_+_162864575 | 1.80 |
ENST00000512163.1
ENST00000393929.1 ENST00000340828.2 ENST00000511683.2 ENST00000510097.1 ENST00000511490.2 ENST00000510664.1 |
CCNG1
|
cyclin G1 |
chr7_+_139529040 | 1.79 |
ENST00000455353.1
ENST00000458722.1 ENST00000411653.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr17_+_40932610 | 1.78 |
ENST00000246914.5
|
WNK4
|
WNK lysine deficient protein kinase 4 |
chr16_+_28986134 | 1.74 |
ENST00000352260.7
|
SPNS1
|
spinster homolog 1 (Drosophila) |
chr5_-_173173171 | 1.70 |
ENST00000517733.1
ENST00000518902.1 |
CTB-43E15.3
|
CTB-43E15.3 |
chr10_+_7745303 | 1.65 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chr16_+_28986085 | 1.64 |
ENST00000565975.1
ENST00000311008.11 ENST00000323081.8 ENST00000334536.8 |
SPNS1
|
spinster homolog 1 (Drosophila) |
chr17_-_8027402 | 1.62 |
ENST00000541682.2
ENST00000317814.4 ENST00000577735.1 |
HES7
|
hes family bHLH transcription factor 7 |
chr17_-_38821373 | 1.62 |
ENST00000394052.3
|
KRT222
|
keratin 222 |
chr7_+_94139105 | 1.59 |
ENST00000297273.4
|
CASD1
|
CAS1 domain containing 1 |
chr9_-_116861337 | 1.58 |
ENST00000374118.3
|
KIF12
|
kinesin family member 12 |
chr2_+_87808725 | 1.55 |
ENST00000413202.1
|
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr7_+_100136811 | 1.51 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
chr14_+_102196739 | 1.46 |
ENST00000556973.1
|
RP11-796G6.2
|
Uncharacterized protein |
chr16_+_31213206 | 1.45 |
ENST00000561916.2
|
C16orf98
|
chromosome 16 open reading frame 98 |
chr15_-_63674218 | 1.45 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
chr14_-_23822061 | 1.40 |
ENST00000397260.3
|
SLC22A17
|
solute carrier family 22, member 17 |
chr7_-_101212244 | 1.39 |
ENST00000451953.1
ENST00000434537.1 ENST00000437900.1 |
LINC01007
|
long intergenic non-protein coding RNA 1007 |
chr2_-_190044480 | 1.37 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr8_-_40755333 | 1.37 |
ENST00000297737.6
ENST00000315769.7 |
ZMAT4
|
zinc finger, matrin-type 4 |
chr11_+_7626950 | 1.35 |
ENST00000530181.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr17_-_44896047 | 1.35 |
ENST00000225512.5
|
WNT3
|
wingless-type MMTV integration site family, member 3 |
chr8_+_143530791 | 1.35 |
ENST00000517894.1
|
BAI1
|
brain-specific angiogenesis inhibitor 1 |
chr19_-_16008880 | 1.34 |
ENST00000011989.7
ENST00000221700.6 |
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2 |
chr22_-_30642728 | 1.32 |
ENST00000403987.3
|
LIF
|
leukemia inhibitory factor |
chrX_-_1331527 | 1.31 |
ENST00000381567.3
ENST00000381566.1 ENST00000400841.2 |
CRLF2
|
cytokine receptor-like factor 2 |
chr10_+_7745232 | 1.29 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chrX_-_25034065 | 1.29 |
ENST00000379044.4
|
ARX
|
aristaless related homeobox |
chr16_+_30080857 | 1.28 |
ENST00000565355.1
|
ALDOA
|
aldolase A, fructose-bisphosphate |
chr20_+_34742650 | 1.27 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr17_+_43239191 | 1.27 |
ENST00000589230.1
|
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
chr6_+_151561085 | 1.26 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr20_+_36012051 | 1.26 |
ENST00000373567.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr10_+_62538248 | 1.25 |
ENST00000448257.2
|
CDK1
|
cyclin-dependent kinase 1 |
chrX_-_154493791 | 1.21 |
ENST00000369454.3
|
RAB39B
|
RAB39B, member RAS oncogene family |
chr16_-_28303360 | 1.21 |
ENST00000501520.1
|
RP11-57A19.2
|
RP11-57A19.2 |
chr17_+_79495397 | 1.21 |
ENST00000417245.2
ENST00000334850.7 |
FSCN2
|
fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) |
chr19_+_39916575 | 1.19 |
ENST00000601124.1
|
CTB-60E11.4
|
CTB-60E11.4 |
chr20_-_23618582 | 1.18 |
ENST00000398411.1
ENST00000376925.3 |
CST3
|
cystatin C |
chr14_+_24779376 | 1.14 |
ENST00000530080.1
|
LTB4R2
|
leukotriene B4 receptor 2 |
chr1_-_92351769 | 1.10 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
chrX_-_11129229 | 1.10 |
ENST00000608176.1
ENST00000433747.2 ENST00000608576.1 ENST00000608916.1 |
RP11-120D5.1
|
RP11-120D5.1 |
chr10_+_62538089 | 1.10 |
ENST00000519078.2
ENST00000395284.3 ENST00000316629.4 |
CDK1
|
cyclin-dependent kinase 1 |
chr3_-_149093499 | 1.09 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr3_-_146262488 | 1.09 |
ENST00000487389.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr3_-_129375556 | 1.08 |
ENST00000510323.1
|
TMCC1
|
transmembrane and coiled-coil domain family 1 |
chr2_-_197226875 | 1.08 |
ENST00000409111.1
|
HECW2
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
chr12_+_57998400 | 1.07 |
ENST00000548804.1
ENST00000550596.1 ENST00000551835.1 ENST00000549583.1 |
DTX3
|
deltex homolog 3 (Drosophila) |
chr14_+_96949319 | 1.06 |
ENST00000554706.1
|
AK7
|
adenylate kinase 7 |
chr16_+_15596123 | 1.06 |
ENST00000452191.2
|
C16orf45
|
chromosome 16 open reading frame 45 |
chr1_-_32384693 | 1.05 |
ENST00000602683.1
ENST00000470404.1 |
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2 |
chr2_+_121493717 | 1.02 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
chr10_-_75012360 | 1.01 |
ENST00000416782.2
ENST00000372945.3 ENST00000372940.3 |
MRPS16
|
mitochondrial ribosomal protein S16 |
chr2_+_87769459 | 1.00 |
ENST00000414030.1
ENST00000437561.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr3_+_112929850 | 0.99 |
ENST00000464546.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr20_-_36794902 | 0.97 |
ENST00000373403.3
|
TGM2
|
transglutaminase 2 |
chr15_-_75134992 | 0.97 |
ENST00000568667.1
|
ULK3
|
unc-51 like kinase 3 |
chr19_-_51141196 | 0.96 |
ENST00000338916.4
|
SYT3
|
synaptotagmin III |
chr12_+_64173583 | 0.94 |
ENST00000261234.6
|
TMEM5
|
transmembrane protein 5 |
chr12_+_78359999 | 0.94 |
ENST00000550503.1
|
NAV3
|
neuron navigator 3 |
chr1_-_40098672 | 0.94 |
ENST00000535435.1
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like |
chr17_+_60447579 | 0.93 |
ENST00000450662.2
|
EFCAB3
|
EF-hand calcium binding domain 3 |
chr8_+_86099884 | 0.92 |
ENST00000517476.1
ENST00000521429.1 |
E2F5
|
E2F transcription factor 5, p130-binding |
chr17_-_15502111 | 0.90 |
ENST00000354433.3
|
CDRT1
|
CMT1A duplicated region transcript 1 |
chr18_+_3411595 | 0.87 |
ENST00000552383.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr1_-_201096312 | 0.87 |
ENST00000449188.2
|
ASCL5
|
achaete-scute family bHLH transcription factor 5 |
chr7_-_100808394 | 0.86 |
ENST00000445482.2
|
VGF
|
VGF nerve growth factor inducible |
chr6_+_151561506 | 0.84 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr17_-_3499125 | 0.84 |
ENST00000399759.3
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1 |
chr9_-_112970436 | 0.84 |
ENST00000400613.4
|
C9orf152
|
chromosome 9 open reading frame 152 |
chr16_-_55867146 | 0.83 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr7_-_2354099 | 0.83 |
ENST00000222990.3
|
SNX8
|
sorting nexin 8 |
chr3_+_159557637 | 0.83 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr14_+_24779340 | 0.81 |
ENST00000533293.1
ENST00000543919.1 |
LTB4R2
|
leukotriene B4 receptor 2 |
chr15_-_63674034 | 0.81 |
ENST00000344366.3
ENST00000422263.2 |
CA12
|
carbonic anhydrase XII |
chr5_+_133861339 | 0.80 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
chrX_+_48455866 | 0.80 |
ENST00000376729.5
ENST00000218056.5 |
WDR13
|
WD repeat domain 13 |
chr8_+_98788003 | 0.80 |
ENST00000521545.2
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
chr9_-_123676827 | 0.80 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr14_+_65453432 | 0.80 |
ENST00000246166.2
|
FNTB
|
farnesyltransferase, CAAX box, beta |
chr19_-_45735138 | 0.79 |
ENST00000252482.3
|
EXOC3L2
|
exocyst complex component 3-like 2 |
chr19_-_33360647 | 0.78 |
ENST00000590341.1
ENST00000587772.1 ENST00000023064.4 |
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 |
chr17_-_39041479 | 0.76 |
ENST00000167588.3
|
KRT20
|
keratin 20 |
chr12_-_89919965 | 0.76 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr20_+_46130619 | 0.75 |
ENST00000372004.3
|
NCOA3
|
nuclear receptor coactivator 3 |
chrX_-_10645724 | 0.75 |
ENST00000413894.1
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr11_+_63870660 | 0.75 |
ENST00000246841.3
|
FLRT1
|
fibronectin leucine rich transmembrane protein 1 |
chr9_-_130679257 | 0.75 |
ENST00000361444.3
ENST00000335791.5 ENST00000343609.2 |
ST6GALNAC4
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
chr2_+_74685413 | 0.74 |
ENST00000233615.2
|
WBP1
|
WW domain binding protein 1 |
chrX_+_54834791 | 0.74 |
ENST00000218439.4
ENST00000375058.1 ENST00000375060.1 |
MAGED2
|
melanoma antigen family D, 2 |
chr4_-_38806404 | 0.73 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
chr12_+_123459127 | 0.72 |
ENST00000397389.2
ENST00000538755.1 ENST00000536150.1 ENST00000545056.1 ENST00000545612.1 ENST00000538628.1 ENST00000545317.1 |
OGFOD2
|
2-oxoglutarate and iron-dependent oxygenase domain containing 2 |
chr10_-_33623310 | 0.72 |
ENST00000395995.1
ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1
|
neuropilin 1 |
chr16_-_21863541 | 0.72 |
ENST00000543654.1
|
NPIPB4
|
nuclear pore complex interacting protein family, member B4 |
chr8_+_37887772 | 0.71 |
ENST00000338825.4
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1 |
chr8_-_79717750 | 0.70 |
ENST00000263851.4
ENST00000379113.2 |
IL7
|
interleukin 7 |
chr17_+_4046964 | 0.69 |
ENST00000573984.1
|
CYB5D2
|
cytochrome b5 domain containing 2 |
chrX_+_9431324 | 0.69 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr5_-_20575959 | 0.69 |
ENST00000507958.1
|
CDH18
|
cadherin 18, type 2 |
chr4_+_113970772 | 0.68 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chr3_-_9834463 | 0.68 |
ENST00000439043.1
|
TADA3
|
transcriptional adaptor 3 |
chr22_-_30866564 | 0.66 |
ENST00000435069.1
ENST00000415957.2 ENST00000540910.1 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
chr10_-_103599591 | 0.65 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
chr17_-_57229155 | 0.65 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
chr1_-_24469602 | 0.65 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr13_+_36050881 | 0.63 |
ENST00000537702.1
|
NBEA
|
neurobeachin |
chrX_+_70443050 | 0.63 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
chr18_+_3412005 | 0.63 |
ENST00000401449.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr2_-_175711978 | 0.62 |
ENST00000409089.2
|
CHN1
|
chimerin 1 |
chr1_-_45140074 | 0.62 |
ENST00000420706.1
ENST00000372235.3 ENST00000372242.3 ENST00000372243.3 ENST00000372244.3 |
TMEM53
|
transmembrane protein 53 |
chr1_+_240255166 | 0.62 |
ENST00000319653.9
|
FMN2
|
formin 2 |
chr19_+_5681011 | 0.61 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
chr12_-_121342170 | 0.61 |
ENST00000353487.2
|
SPPL3
|
signal peptide peptidase like 3 |
chr17_-_15501932 | 0.60 |
ENST00000583965.1
|
CDRT1
|
CMT1A duplicated region transcript 1 |
chr17_-_40835076 | 0.60 |
ENST00000591765.1
|
CCR10
|
chemokine (C-C motif) receptor 10 |
chr20_+_8112824 | 0.60 |
ENST00000378641.3
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific) |
chr1_-_153513170 | 0.59 |
ENST00000368717.2
|
S100A5
|
S100 calcium binding protein A5 |
chr16_-_88752889 | 0.59 |
ENST00000332281.5
|
SNAI3
|
snail family zinc finger 3 |
chr17_+_39975544 | 0.58 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr7_-_100808843 | 0.58 |
ENST00000249330.2
|
VGF
|
VGF nerve growth factor inducible |
chr9_-_128246769 | 0.58 |
ENST00000444226.1
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1 |
chr1_-_92351666 | 0.58 |
ENST00000465892.2
ENST00000417833.2 |
TGFBR3
|
transforming growth factor, beta receptor III |
chr5_-_180237082 | 0.56 |
ENST00000506889.1
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr17_+_39975455 | 0.56 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr20_+_60174827 | 0.55 |
ENST00000543233.1
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal) |
chr21_-_46340884 | 0.55 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr3_+_9834227 | 0.54 |
ENST00000287613.7
ENST00000397261.3 |
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
chr12_+_69742121 | 0.54 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr6_-_44233361 | 0.53 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr8_-_66546439 | 0.52 |
ENST00000276569.3
|
ARMC1
|
armadillo repeat containing 1 |
chr2_+_74685527 | 0.52 |
ENST00000393972.3
ENST00000409737.1 ENST00000428943.1 |
WBP1
|
WW domain binding protein 1 |
chr4_-_144826682 | 0.52 |
ENST00000358615.4
ENST00000437468.2 |
GYPE
|
glycophorin E (MNS blood group) |
chr1_-_103574024 | 0.52 |
ENST00000512756.1
ENST00000370096.3 ENST00000358392.2 ENST00000353414.4 |
COL11A1
|
collagen, type XI, alpha 1 |
chr18_+_18943554 | 0.51 |
ENST00000580732.2
|
GREB1L
|
growth regulation by estrogen in breast cancer-like |
chr3_+_111260954 | 0.50 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr3_-_179322436 | 0.50 |
ENST00000392659.2
ENST00000476781.1 |
MRPL47
|
mitochondrial ribosomal protein L47 |
chr2_-_158345341 | 0.49 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
chr2_+_264913 | 0.49 |
ENST00000439645.2
ENST00000405233.1 |
ACP1
|
acid phosphatase 1, soluble |
chr3_-_71774516 | 0.47 |
ENST00000425534.3
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
chr7_+_77469439 | 0.47 |
ENST00000450574.1
ENST00000416283.2 ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr1_-_149812765 | 0.47 |
ENST00000369158.1
|
HIST2H3C
|
histone cluster 2, H3c |
chr1_+_12776118 | 0.45 |
ENST00000332530.3
ENST00000359318.5 |
AADACL3
|
arylacetamide deacetylase-like 3 |
chr20_-_30458491 | 0.45 |
ENST00000339738.5
|
DUSP15
|
dual specificity phosphatase 15 |
chr13_+_28519343 | 0.45 |
ENST00000381026.3
|
ATP5EP2
|
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit pseudogene 2 |
chr1_+_165864800 | 0.45 |
ENST00000469256.2
|
UCK2
|
uridine-cytidine kinase 2 |
chr12_+_21525818 | 0.45 |
ENST00000240652.3
ENST00000542023.1 ENST00000537593.1 |
IAPP
|
islet amyloid polypeptide |
chr3_+_111260856 | 0.45 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr10_-_102045882 | 0.44 |
ENST00000579542.1
|
BLOC1S2
|
biogenesis of lysosomal organelles complex-1, subunit 2 |
chr2_-_71062938 | 0.44 |
ENST00000410009.3
|
CD207
|
CD207 molecule, langerin |
chr1_-_152539248 | 0.44 |
ENST00000368789.1
|
LCE3E
|
late cornified envelope 3E |
chr10_-_79397547 | 0.44 |
ENST00000481070.1
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr2_+_161993465 | 0.44 |
ENST00000457476.1
|
TANK
|
TRAF family member-associated NFKB activator |
chr6_-_15586238 | 0.43 |
ENST00000462989.2
|
DTNBP1
|
dystrobrevin binding protein 1 |
chr3_+_196366616 | 0.43 |
ENST00000426755.1
|
PIGX
|
phosphatidylinositol glycan anchor biosynthesis, class X |
chr6_+_99282570 | 0.43 |
ENST00000328345.5
|
POU3F2
|
POU class 3 homeobox 2 |
chr7_+_139529085 | 0.43 |
ENST00000539806.1
|
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr3_-_179322416 | 0.43 |
ENST00000259038.2
|
MRPL47
|
mitochondrial ribosomal protein L47 |
chr12_-_10978957 | 0.43 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr5_+_150040403 | 0.43 |
ENST00000517768.1
ENST00000297130.4 |
MYOZ3
|
myozenin 3 |
chr10_+_90562487 | 0.42 |
ENST00000404743.4
|
LIPM
|
lipase, family member M |
chr9_+_113431059 | 0.42 |
ENST00000416899.2
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase |
chr7_-_3214287 | 0.42 |
ENST00000404626.3
|
AC091801.1
|
LOC392621; Uncharacterized protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 16.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.9 | 5.8 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.6 | 9.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
1.4 | 4.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 5.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.9 | 4.7 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 8.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 1.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 1.3 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.4 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.9 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 1.0 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.3 | 2.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.3 | 1.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 1.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.3 | 0.9 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.3 | 6.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 1.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.3 | 1.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.3 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 2.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.2 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 4.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.2 | 0.8 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.2 | 0.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.2 | 0.6 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.2 | 1.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.2 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 3.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.7 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.1 | 0.7 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 0.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 1.0 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.1 | 0.5 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.8 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.3 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.1 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.4 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.1 | 2.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.4 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.2 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 0.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) regulation of chromosome condensation(GO:0060623) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.3 | GO:0050803 | regulation of synapse structure or activity(GO:0050803) |
0.0 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 2.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.0 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.3 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.0 | 0.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 2.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 1.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 1.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 2.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 2.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 1.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 1.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 2.0 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 4.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 2.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 2.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.8 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 4.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 2.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 2.3 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 16.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 2.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.1 | 0.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.0 | 4.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 3.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.7 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.4 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.8 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 1.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.9 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 13.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 4.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.2 | 4.8 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.7 | 2.0 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.6 | 1.7 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.5 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 16.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.9 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.4 | 1.3 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.4 | 1.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 3.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.0 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 4.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 9.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 5.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 1.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 5.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 2.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) ER retention sequence binding(GO:0046923) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 0.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 1.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 2.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 1.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 4.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.0 | 0.9 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 2.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.0 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 2.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 19.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 7.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 3.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 2.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 6.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 3.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 4.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 17.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 5.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 2.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 7.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 2.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |